We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBL
2701
CBL Properties
CBL
$1.82B
$52.6K ﹤0.01%
1,370
+443
+48% +$16.4K
MTRX icon
2702
Matrix Service
MTRX
$326M
$52.6K ﹤0.01%
4,586
+3,797
+481% +$45.2K
HMC icon
2703
Honda
HMC
$39.1B
$52.5K ﹤0.01%
2,160
-1,194
-36% -$34.6K
AMTM
2704
Amentum Holdings
AMTM
$5.42B
$52.4K ﹤0.01%
2,010
+1,333
+197% +$41.8K
LZ icon
2705
LegalZoom.com
LZ
$1.35B
$52.3K ﹤0.01%
9,228
+4,434
+92% +$33.6K
FPI
2706
Farmland Partners
FPI
$408M
$52.3K ﹤0.01%
4,657
+1,720
+59% +$19.7K
PLSE icon
2707
Pulse Biosciences
PLSE
$2.43B
$52.2K ﹤0.01%
2,416
+410
+20% +$7.57K
CIG icon
2708
CEMIG Preferred Shares
CIG
$6.26B
$52.1K ﹤0.01%
21,801
+5,180
+31% +$11.4K
NPK icon
2709
National Presto Industries
NPK
$870M
$52.1K ﹤0.01%
380
+116
+44% +$14.9K
PRLB icon
2710
Protolabs
PRLB
$1.79B
$51.9K ﹤0.01%
911
-2,229
-71% -$129K
IVVD icon
2711
Invivyd
IVVD
$158M
$51.9K ﹤0.01%
39,909
+111
+0.3% +$204
HEI icon
2712
HEICO Corp
HEI
$49.8B
$51.8K ﹤0.01%
189
-110
-37% -$35.4K
EVMN
2713
Evommune Inc
EVMN
$405M
$51.7K ﹤0.01%
2,249
-496
-18% -$11.2K
AIP icon
2714
Arteris
AIP
$1.38B
$51.7K ﹤0.01%
3,145
+2,396
+320% +$38K
DHIL
2715
DELISTED
Diamond Hill
DHIL
$51.6K ﹤0.01%
300
-187
-38% -$32K
ATAI icon
2716
AtaiBeckley Inc
ATAI
$2.66B
$51.6K ﹤0.01%
14,572
+13,826
+1,853% +$52.1K
EYPT icon
2717
EyePoint Inc
EYPT
$1.03B
$51.6K ﹤0.01%
4,001
+3,061
+326% +$45.8K
PDS
2718
Precision Drilling
PDS
$999M
$51.6K ﹤0.01%
524
-4,099
-89% -$351K
CORT icon
2719
Corcept Therapeutics
CORT
$12.4B
$51.4K ﹤0.01%
1,276
-1,133
-47% -$42.4K
BVN icon
2720
Compañía de Minas Buenaventura
BVN
$7.69B
$51.4K ﹤0.01%
+1,427
New +$51.5K
CSV icon
2721
Carriage Services
CSV
$641M
$51.4K ﹤0.01%
1,126
+82
+8% +$3.57K
AOSL icon
2722
Alpha and Omega Semiconductor
AOSL
$950M
$51.3K ﹤0.01%
2,315
+1,570
+211% +$34.2K
BY icon
2723
Byline Bancorp
BY
$1.78B
$51K ﹤0.01%
1,617
+52
+3% +$1.63K
KALV
2724
DELISTED
KalVista Pharmaceuticals
KALV
$51K ﹤0.01%
2,534
+2,164
+585% +$34.9K
JBI icon
2725
Janus International
JBI
$700M
$51K ﹤0.01%
9,897
+4,059
+70% +$26.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.